Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A. Braun, Catherine J. Wu, John A. Steinharter et al.|Cancer Cell|2021Cited by 515
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid MalignanciesRomain Guièze, Catherine J. Wu, Vivian M. Liu et al.|Cancer Cell|2019Cited by 361
Landscape of helper and regulatory antitumour CD4+ T cells in melanomaGiacomo Oliveira, Catherine J. Wu, Kari Stromhaug et al.|Nature|2022Cited by 192
Methods for high-dimensional analysis of cells dissociated from cryopreserved synovial tissueJennifer H. Anolik, Laura T. Donlin, Deepak A. Rao et al.|Arthritis Research & Therapy|2018Cited by 130
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Catherine J. Wu, Yang Liu et al.|Blood|2023Cited by 51